Istodax is used to treat lymphoma. Its effect is due to slowing down the growth of malignant cells.
It is a type of anticancer (antitumor) drug that belongs to a group of drugs known as histone deacetylase inhibitors, or HDACs.
Istodax is used to treat a type of cancer called peripheral T-cell lymphoma (PTCL) in patients who have received at least one previous treatment for the disease.
PTCL is a disease in which a type of immune system white blood cell called T cells grows abnormally. Istodax slows or stops the growth of these cancer cells. This medicine has also been shown to kill cancer cells.
Active ingredient: romidepsin
Prescription medicine
